Literature DB >> 21484429

Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

Burçin Tuna1, Kutsal Yörükoglu, Ender Düzcan, Sait Sen, Nalan Nese, Banu Sarsık, Aysegul Akder, Sehnaz Sayhan, Uğur Mungan, Ziya Kirkali.   

Abstract

The clinical management of tumor patients is often strongly influenced by the tumor grade. The presence of heterogeneity is well recognized in a variety of tumors. Overall grade is based on highest grade area identified within a tumor. Urothelial carcinoma often contains different histological grades within the same tumor. This study investigates the impact of a combined grading system on the reproducibility of papillary urothelial neoplasms. A set prepared for an earlier study consisting of ten cases of each category (papillary urothelial neoplasm of low malignant potential (PUNLMP), LGPUC, and HGPUC) was used. Agreement between pairs of pathologists was evaluated using κ statistics for the combined scoring system. Interobserver agreement was fair to substantial as reflected by κ values ranging from 0.24 to 0.74 (mean κ = 0.43). The combined scores of 2 and 3 which included PUNLMP showed the lowest degree of agreement and when this category was excluded from the analysis, interobserver agreement increased significantly (mean κ = 0.65; ranging from 0.43 to 0.92) in terms of combined scores of 4, 5, and 6. PUNLMP has been shown to be the least reproducible component of a combined scoring system even among experienced observers. Exclusion of PUNLMP from grading scheme seems to improve interobserver variability.

Entities:  

Mesh:

Year:  2011        PMID: 21484429     DOI: 10.1007/s00428-011-1072-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

1.  Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Authors:  J W A Oosterhuis; R F M Schapers; M L G Janssen-Heijnen; R P E Pauwels; D W Newling; F ten Kate
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.

Authors:  Bas W G van Rhijn; Geert J L H van Leenders; Bert C M Ooms; Wim J Kirkels; Alexandre R Zlotta; Egbert R Boevé; Adriaan C Jöbsis; Theo H van der Kwast
Journal:  Eur Urol       Date:  2009-09-11       Impact factor: 20.096

Review 3.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

4.  Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.

Authors:  W A Wells; P A Carney; M S Eliassen; M R Grove; A N Tosteson
Journal:  Am J Surg Pathol       Date:  2000-05       Impact factor: 6.394

5.  Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Authors:  L Cheng; R M Neumann; A Nehra; B E Spotts; A L Weaver; D G Bostwick
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

6.  Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential.

Authors:  Y Fujii; S Kawakami; F Koga; T Nemoto; K Kihara
Journal:  BJU Int       Date:  2003-10       Impact factor: 5.588

7.  Analysis of the performance of pathologists in the grading of bladder tumors.

Authors:  E C Ooms; W A Anderson; C L Alons; M E Boon; R W Veldhuizen
Journal:  Hum Pathol       Date:  1983-02       Impact factor: 3.466

8.  Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.

Authors:  Kutsal Yorukoglu; Burcin Tuna; Emel Dikicioglu; Ender Duzcan; Aydin Isisag; Sait Sen; Ugur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2003-10-08       Impact factor: 4.064

9.  FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.

Authors:  Bas W G van Rhijn; Theo H van der Kwast; André N Vis; Wim J Kirkels; Egbert R Boevé; Adriaan C Jöbsis; Ellen C Zwarthoff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

Review 10.  The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?

Authors:  Jonathan I Epstein
Journal:  Crit Rev Oncol Hematol       Date:  2003-08       Impact factor: 6.312

View more
  2 in total

1.  Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.

Authors:  Ji Eun Kwon; Nam Hoon Cho; Yeong-Jin Choi; So Dug Lim; Yong Mee Cho; Sun Young Jun; Sanghui Park; Young A Kim; Sung-Sun Kim; Mi Sun Choe; Jung-Dong Lee; Dae Yong Kang; Jae Y Ro; Hyun-Jung Kim
Journal:  Diagn Pathol       Date:  2017-07-24       Impact factor: 2.644

2.  First approach to distinguish between cardiac and arteriosclerotic emboli of individual stroke patients applying the histological THROMBEX-classification rule.

Authors:  Florian C Roessler; Nicolas Kalms; Florian Jann; Andrè Kemmling; Julika Ribbat-Idel; Florian Stellmacher; Inke R König; Marcus Ohlrich; Georg Royl
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.